Dipyridamole (AnazaoHealth Corporation)
Welcome to the PulseAid listing for the Dipyridamole drug offered from AnazaoHealth Corporation. This Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AnazaoHealth Corporation |
NON-PROPRIETARY NAME: | Dipridamole |
SUBSTANCE NAME: | DIPYRIDAMOLE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Decreased Platelet Aggregation [PE],Platelet Aggregation Inhibitor [EPC] |
ROUTE: | INTRAVENOUS |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | UNAPPROVED DRUG OTHER |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
Dipyridamole HUMAN PRESCRIPTION DRUG Details:
Item Description | Dipyridamole from AnazaoHealth Corporation |
LABELER NAME: | AnazaoHealth Corporation |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 5(mg/mL) |
START MARKETING DATE: | 2012-05-23 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 51808-204_71f96ee3-a363-4345-9ab6-5270ae323fab |
PRODUCT NDC: | 51808-204 |
APPLICATION NUMBER: | |
Other DIPYRIDAMOLE Pharmaceutical Manufacturers / Labelers: